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Nephrotoxic serum nephritis with hypertension: Amelioration by
antihypertensive therapy. We have examined the effects of antihyper-
tensive therapy on glomerular dynamics and on the clinical and mor-
phologic features of a model of nephrotoxic serum nephritis (NSN) in
which hypertension occurs. NSN was induced in uninephrectomized
male Sprague Dawley rats, which drank 0.9% sodium chloride ad
libitum. One-half were assigned randomly to a treated group whose
blood pressure was normalized on a regimen of reserpine, hydralazine,
and hydrochlorothiazide. Hypertension continued throughout the 6
weeks of study in untreated rats (blood pressure 148 5 vs. 103 3mm
Hg in treated rats, P < 0.01). Urinary protein excretion was greater (437
110 vs. 254 81 mg124 hr, P < 0.005), and serum albumin lower (1.6
0.4 vs. 2.9 0.3 gIdl, P < 0.01) in hypertensive animals. Diffuse
glomerular erido- and extracapillary proliferation and artenolar medial
hypertrophy were observed frequently in nephritic rats with untreated
hypertension. By contrast, structural abnormalities were limited pri-
marily to focal segmental proliferation involving fewer than one-third of
glomeruli in the absence of vascular changes in treated normotensive
rats. Micropuncture studies performed 8 to 16 days after induction of
nephritis showed a reduction in glomerular capillary pressure (46 I
vs. 55 1 mm Hg, P < 0.001), glomerular plasma flow rate (115 20
vs. 160 20 nI/mm, P < 0.01), and single nephron filtration rate (42
4 vs. 56 5 nI/mm, P < 0.001) with antihypertensive treatment,
suggesting that a hemodynamic mechanism may have been responsible
for enhanced glomerular injury in the hypertensive nephritic animals.
Néphrite sérique nephrotoxique avec hypertension: Amelioration par le
traitement antihypertenseur. Nous avons examine les effets d'un traite-
ment antihypertenseur sur Ia dynamique glomerulaire et les caractéris-
tiques cliniques et morphologiques d'un modèle de nephrite sérique
néphrotoxique (NSN) au cours duquel une hypertension survient. La
NSN a ete induite chez des rats males Sprague-Dawley uninéphrecto-
misés, qui buvaient du chlorure de sodium a 0,9% ad libitum. La moitié
ont été assignés au hasard a un groupe de traitement dont Ia pression
sanguine était normalisée par une association de réserpine,
d'hydralazine, et d'hydrochlorothiazide. L'hypertension a persisté pen-
dant les 6 semaines de l'étude chez des rats non traités (pression
sanguine 148 5 contre 103 3 mm Hg chez les rats traités, P <0,001).
La protéinurie était plus forte (437 110 contre 254 81 mg/24 hr, P
<0,005), et l'albuminémie plus basse (1,6 0,4 contre 2,9 0,3 g/dl,
P < 0,01) chez les animaux hypertendus. Une proliferation glomerulaire
diffuse endo- et extra-capillaire et une hypertrophie médiale artériolaire
étaient comniunément observes chez les rats néphritiques avec hyper-
tension non traités. A l'opposé, les anomalies structurelles étaient
géneralement limitées a une proliferation segmentaire et focale portant
sur moms d'un tiers des glomerules en l'absence de changements
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vasculaires chez les rats normotendus traités. Des etudes de
microponction faites 8 a 16 jours après induction de Ia néphrite ont
montré une reduction de la pression capillaire glomerulaire (46 1
contre 55 1 mm Hg, P < 0,001),du flux plasmatique glomerulaire (115
20 contre 160 20 nm/mm, P < 0,01) et du debit de filtration
glomerulaire individuel (42 4 contre 56 5 nI/mm, P < 0,001) avec le
traitement antihypertenseur, suggerant un mécanisme hemodynamique
qui pourrait avoir été responsable de Ia stimulation des lesions
glomérulaires chez les animaux nephritiques hypertendus.
Although it is agreed generally that hypertension contributes
to the progression of parenchymal renal disease, the exact
mechanism by which elevated blood pressure damages the
kidney is not known. Conventionally, hypertension is thought
to cause vascular sclerosis, which in turn becomes responsible
for ischemic glomerular sclerosis. However, on the basis of
recent studies performed in experimental models of hyperten-
sion, generally in the setting of reduced rena, mass, it has been
proposed that hypertension may damage the kidney directly by
transmission of elevated systemic pressure [lJ.
We have shown that vascular and glomerular damage are
aggravated markedly when clip hypertension is superimposed
on NSN in the rat, suggesting that the effects of hypertension
may be magnified in the diseased kidney [2]. Since hypertension
is not typically a concomitant of experimental glomerulonephri-
tis, the effects of antihypertensive therapy on models of
nephritis that themselves cause hypertension have not been
investigated previously [11. Having developed recently a model
of NSN in which hypertension is a regular feature, we now
examine the effects of antihypertensive therapy on the clinical
and morphologic manifestations of nephritis and correlate these
with glomerular hemodynamics. Normalization of blood pres-
sure ameliorated markedly the clinical and histologic manifes-
tations of this hypertensive form of glomerulonephritis. Micro-
puncture studies performed 8 to 16 days after induction of
nephritis showed a reduction in glomerular capillary pressure
(PGC), glomerular plasma flow rate, and single nephron glomer-
ular filtration rate with antihypertensive treatment, consistent
with the hypothesis that a hemodynamic mechanism underlies
the enhanced vascular and glomerular injury that occurs when
hypertension and nephritis are combined.
Methods
Clinical and morphologic studies. Sixteen male Sprague-
Dawley rats, initially weighing 180 to 275 g, underwent right
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Table 1. Treatment of hypertension in nephrotoxic serum nephritis. Observations made after 6 weeks of treatment.
BP
,nm Hg
Heart weight
g
Proteinuria
mg/24 hr
SAIbmj,
gidi
CCR
mi/mm
Hypertensive (untreated) N = 7 151 10 1.53 0.21 437 110 1.6 0.4 0.7 0.2
Normotensive (treated) N = 8 104 4 1.11 0.07 254 81 2.9 0.3 0.8 0.1
P Value < 0.01 <0.001 <0.05 <0.01 NS
unilateral nephrectomy via a flank incision. The gamma globulin
fraction of goat anti-rat nephrotoxic serum was administered
intravenously in a dose of 0.2 cc/lOO g of body wt on 2
consecutive days following presensitization by subcutaneous
administration of goat gamma globulin (Cappel Laboratories,
Cochranville, Pennsylvania, USA) in complete Freund's adju-
vant (Difco Laboratories, Detroit, Michigan, USA). The prep-
aration in the goat of nephrotoxic serum with anti-rat glomeru-
lar basement membrane antibody activity has been described
previously [2]. Animals were assigned randomly to a treatment
group that received hydralazine 100 mg/liter (Sigma Chemical
Company, St. Louis, Missouri, USA), reserpine 2 mg/liter
(Sigma Chemical Company), and hydrochlorothiazide 200
mg/liter (Merck, Sharp and Dohme, West Point, Pennsylvania,
USA) dissolved in 0.9% saline and administered freely as
drinking solution. One animal was given furosemide 50 mg/liter
(Hoecht-Roussell Pharmaceuticals, Somerville, New Jersey,
USA) in place of hydrochiorothiazide during the last 2 weeks of
therapy. A control group received only 0.9% saline, The
animals were fed commercial rodent chow tRodent Lab Chow
#5001, Ralston-Purina, St. Louis, Missouri, USA). Twenty-
four-hr urine specimens for determination of urinary protein
and creatinine excretion were collected under oil immediately
after administration of nephrotoxic serum and after 2, 4, and 6
weeks. Rat tail blood pressure was measured at 2-week inter-
vals under light pentobarbital anesthesia utilizing a programmed
electrosphygmomanometer and pneumatic pulse transducer
(Narco Bio Systems, Houston, Texas, USA) as described
previously [2]. Six weeks after initiation of therapy, animals
were sacrificed; the heart and body wt were determined.
One-half of each kidney was sectioned in the coronal plane and
fixed in 10% buffered formalin. Renal tissue from all animals
who died spontaneously between the fourth and sixth weeks
was processed similarly for histologic analysis. Coded sections
cut at approximately 4r were stained with periodic acid silver
methenamine and counterstained with hematoxylin and eosin.
Severity of histologic abnormalities was rated on a scale of 0 to
3 as follows: 0 = glomeruli normal or showing mild mesangial
widening; 1 = segmental or global proliferative or sclerosing
glomerular lesions involving fewer than one-third of glomeruli
in association with mesangial widening; 2 segmental or global
proliferative or sclerosing glomerular lesions involving one-
third to two-thirds of glomeruli in association with mesangial
widening; 3 diffuse proliferative endo- and extracapillary
glomerulonephritis involving nearly all glomeruli. Arteriolar
medial hypertrophy was evaluated as present or absent. Serum
creatinine and blood urea nitrogen were determined on serum
obtained at sacrifice (Auto-analyzer, Technicon Instrument
Corp., Tarrytown, New York, USA). The Student's t test for
unpaired data was used for statistical evaluation. Data are
expressed as the group mean SEM.
Giomerular hemodynamic studies. NSN was induced as described
above in 16 Sprague-Dawley male rats initially weighing 190 to 300g.
After collection of a 24-hr urine, animals were assigned randomly to
no treatment or to antihypertensive therapy. Where data were
available, it became evident that rats receiving antihypertensive
therapy ate and drank less by 15 and 28%, respectively. Eight to 16
days later micropuncture studies were performed following an over-
night fast. Under pentobarbital anesthesia animals were prepared for
micropuncture as described previously [3]. Volume losses incurred
during surgery were replaced with pooled serum collected from other
nephritic rats in a volume equal to 1% of body wt, and containing 60
p. Ci tritiated inulin (New England Nuclear Corp., Boston, Massa-
chusetts, USA). This was followed by an intravenous infusion of
saline at a rate of 1.5 cc/hr. containing 30 p. Ci tritiated inulin per ml.
After a 60-mm equilibration period, timed proximal tubular fluid
samples and timed urine and blood collections were obtained in order
to measure single nephron and whole kidney glomerular filtration
rate. The activity of tritiated inulin was determined as described
previously [3]. Hydraulic pressure was measured in proximal tubules
utilizing a servo-nuffing micropressure measuring system (WPI In-
struments, New Haven, Connecticut, USA). Stop-flow hydrostatic
pressure (PSF) was determined after blockage of an early proximal
convoluted tubule with a Sudan black-stained oil column. Approxi-
mately three measurements of each parameter were made in each
animal. Efferent arteriolar blood collected in a heparinized
micropipet was transferred to a constant bore capillary tube, centri-
fuged in a microhematocrit tube (International Equipment Co.,
Boston, Massachusetts, USA), and the hematocrit determined using
an eyepiece micrometer. Systemic colloid osmotic pressure (i) was
determined from systemic arterial blood as described previously [4].
The following calculations were made:
GC = SF + 1TA
Single nephron filtration fraction =
HctM'ereflt (lHCtEfferent) /FlCtEfferent (lHct&.fferene)} x 100
Results
Elevated systolic pressure ranging from 136 to 162 mm Hg
developed in all animals in the untreated control group. The
increase in blood pressure was observed 2 weeks after induc-
tion of nephritis, with a mean value of 144 6 mm Hg. Blood
pressure remained elevated throughout the study, averaging 151
10 mm Hg in the sixth week (Table 1). Systolic blood
pressures in rats on the antihypertensive regimen remained
normal throughout the period of study, averaging 104 4 mm
Hg at 2 weeks and 104 9 mm Hg at 6 weeks. One rat
developed hypertension despite therapy and was excluded from
the study. Corroborating the differences in blood pressure,
heart wt at sacrifice or death was greater in the hypertensive
rats than in the treated normotensives (1.53 21 g vs. 1.11
0.7 g, P < 0.001) (Table 1).
No significant difference in the level of proteinuria was
observed between the two groups prior to randomization or
after 2 weeks of nephritis (346 57 vs. 366 56 mg/24 hr, NS).
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Fig. 1. Renal histology at 6 weeks in rats with NSN and untreated
hypertension. Diffuse endo- and extracapillary proliferation in
glomeruli. Medial hypertrophy of arterioles and prearterioles. Tubular
atrophy, interstitial inflammation, and proteinaceous tubular casts.
At 4 weeks, urinary protein excretion was greater in the
hypertensives with 24-hr excretion of 553 127 mg, compared
to 303 85 mg in the normotensive rats (P <: 0.01). This
difference was sustained at 6 weeks, 437 110 mg/24 hr in the
hypertensives vs. 254 81 mg/24 hr in norinotensives (P <
0.01) (Table 1). A greater reduction in serum albumin, reflecting
heavier urinary protein loss, was observed in the hypertensive
animals, 1.6 4 g/dl, compared to 2.9 3 g/dl in the
normotensive rats (P < 0.01) (Table 1). Ascites was universal in
the hypertensives but generally absent in treated rats. Greater
body wt at sacrifice or death correlated with the presence of
ascites in the hypertensive rats (361 23 g vs. 295 35 g in
normotensives, P < 0.01). No significant difference in serum
creatinine or in creatinine clearance was observed between the
two groups at the time of sacrifice (Table 1).
Diffuse entdo- and extracapillary proliferation were observed
frequently in glomeruli of hypertensive rats at the time of death
or sacrifice at 4 to 6 weeks. Arterioles and prearterioles in the
majority showed medial hypertrophy. Tubular atrophy and
interstitial inflammation generally paralleled glomerular in-
volvement. Dilated tubules filled with casts composed of
proteinaceous material were present in many specimens (Fig.
1). With aritihypertensive therapy, structural abnormalities
after 4 to 6 weeks were limited generally to focal segmental
proliferation involving fewer than one-third of glomeruli.
Tubulointerstitial abnormalities were minor, and vascular me-
dial hypertrophy was absent (Fig. 2).
In the hypertensive rats, mean histologic grade at 4 to 6
weeks, according to the severity scale of 0 to 3, was 2.6 0.2,
compared to a mean grade of 1.3 0.3 in the normotensive
animals (P < 0.001). As shown in Table 2, five of eight
normotensive treated animals had a histology grade of 0 to I and
only one a grade of 3.
Micropuncture studies were performed in a group of 18
animals 8 to 16 days after induction of nephritis. Renal his-
tologic abnormalities at this time were limited primarily to focal
proliferative glomerular lesions involving fewer than one-third
of glomeruli in both treated and untreated animals. Mean blood
pressure was normal in the treated rats, 111 2 mm Hg,
Fig. 2. Renal histology at 6 weeks in nephritic rats rendered
normotensive with treatment. Focal segmental proliferation and mesan-
gial widening in glomeruli. No arteriolar abnormalities.
Table 2. Effect of antihypertensive therapy on glomerular structural
damage in nephrotoxic serum nephritis. Histologic severity graded
after 6 weeks of treatment
Glomerular structural damage
Mean grade
severity Grade 0 to I Grade 2 Grade 3
Hypertensive
(untreated)N=7
Normotensive
(treated)N=8
2.6±0.2
1.4±0.3
0
5
2
2
5
1
compared to 169 5 mm Hg in the hypertensive animals (P <
0.001) (Table 3). Ascites was present universally in the
hypertensives but absent generally in normotensives, despite
slightly higher 1A in the former (19 1 vs. 18 1 mm Hg, P <
0.01). Under the dissecting microscope, tubules appeared ho-
mogeneous by inspection, thereby minimizing any possible bias
in selection of tubules for puncture. Normotensive rats exhib-
ited lower whole kidney glomerular filtration rate (0.7 0.1 vs.
1.0 0.2 mI/mm, P < 0.01), single nephron filtration rate (43
7 vs. 56 6 nI/mm, P < 0.01) and glomerular plasma flow rate
(115 20 vs. 160 20 nI/mm, P < 0.01). Glomerular capillary
pressure, estimated from stop—flow pressure, was lower also in
normotensive rats (46 1 vs. 55 1 mm Hg, P < 0.001).
Proximal tubular pressure did not differ between the two
groups.
Discussion
The mechanism by which hypertension damages the kidney
in renal disease and the relative importance of its contribution
to the progression of renal insufficiency are poorly defined.
Many believe that hypertension exerts its adverse effects
through vasoconstriction and intrarenal vascular sclerosis,
which in turn become responsible for glomerular sclerosis.
Recent studies in experimental models of hypertension sug-
gest, however, that hypertension may damage the glomerulus
directly by transmission of elevated systemic pressure rather
• ' tf>4cflfkflk
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Table 3. Effect of antihypertensive therapy on glomerular dynamics in nephrotoxic serum nephritis. Observation made after 8 to 16
days of treatment
BP
mm Hg
GFR
milmin
PGC
mm Hg
QA
ni/mm
SNGFR
ni/mm
Hypertensive (untreated) N = 8 169 5 1.0 0.2 55 1 160 20 56 5
Normotensive (treated) N = 8 111 2 0.7 0.1 46 1 115 20 42 4
P Value <0.001 <0.01 <0.001 <0.01 <0.001
than through vasoconstriction and ischemia [1]. Azar et al have
proposed that adaptive reductions in renal resistance occur in
experimental hypertension to maintain single nephron filtration
rate in models with a reduced number of functioning nephrons,
present either genetically or resulting from uninephrectomy [5—
71. Elevated glomerular capillary pressure and/or perfusion are
believed to be responsible for glomerular damage by a mecha-
nism analogous to that which has been hypothesized from
studies in the remnant kidney model [8].
Our observations on the evolution of poststreptococcal gb-
merulonephritis and Berger's IgA nephropathy suggest that
renal injury due to hypertension in man is enhanced in the
presence of underlying glomerular disease [9—111. This infer-
ence is based on the relative severity of intrarenal vascular
disease associated with mild hypertension of brief duration, and
the high correlation among hypertension, vascular sclerosis,
and glomerular damage.
To assess the vulnerability of the diseased kidney to the
damaging effects of hypertension, we have examined previously
the effects of clip hypertension on the course of NSN in the rat
[2]. In our experimental design, clip hypertension alone was
compared to NSN with superimposed hypertension at the same
level of blood pressure. The combination of clip hypertension
with NSN resulted in marked proteinuria, in widespread severe
vascular damage, and in diffuse endo- and extracapillary prolif-
eration and sclerosis in glomeruli, which were never observed
with comparable levels of hypertension alone or with nephritis
in the absence of hypertension. We concluded that both the
renal vessels and glomeruli in nephritis are highly susceptible to
the adverse effects of systemic hypertension.
Mild nephrotoxic serum nephritis is accompanied by an increase in
P and in the transcapillary hydrostatic pressure difference, which
occur presumably as an adaptation to a drop in the glomerular
capillary ultrafiltration coefficient. Thus, single nephron filtration rate
is maintained despite widespread morphologic glomerular injury 112].
Rats with more severe nephritis and depressed whole kidney and
single nephron filtration rate also demonstrate elevated GC [11.
It has been proposed that the adaptive hemodynamic alteration
that occurs in experimental gbomerulonephritis (elevated PGC) accel-
erates morphologic damage and functional deterioration. Systemic
hypertension, in magnifying this increased hydraulic stress, may
further aggravate vascular and glomerular damage. We have hypoth-
esized that hypertension produces excessive vascular and gbomerular
damage in the nephritic kidney because adaptive changes in afl'erent
arteriolar resistance, by impairing autoregulation, allow enhanced
transmission of elevated systemic pressure to the preglomerular
vessels and gbomerular capifiaries [11. Further, these structures may
be more vulnerable to hydraulic stress in the diseased kidney [131.
The results of the present study support this hypothesis. The mech-
anisms by which such increases in pressure or perfusion cause
damage to arterioles and glomerular capillaries are not known.
We have shown here that treatment of hypertension amelio-
rates significantly the clinical and histologic manifestations of a
form of NSN in which hypertension is a feature of the disease.
The level of urinary protein excretion was decreased and serum
albumin concentration declined less in nephritic rats rendered
normotensive with treatment. These clinical parameters cone-
lated with markedly diminished severity of gbomerular, vascular
and tubulointerstitial damage in treated rats. The findings of
lower GC and glomerular plasma flow after 8 to 16 days of
antihypertensive therapy and of reduced glomerular injury after
6 weeks suggest that the decreased severity of vascular and
glomerular injury in nephritic animals rendered normotensive
can be attributed to reduced glomerular hydraulic stress, Whole
kidney filtration rate (as estimated by creatinine clearance) did
not differ between the two groups at 6 weeks when the animals
were sacrificed. One may infer from this equality of glomerular
filtration rate, despite severe structural glomerular damage in
the hypertensive rats, that filtration was maintained through
increases in GC and glomerular plasma flow.
This study does not include control observations designed to
evaluate the effect of comparable hypertension alone (without
nephritis) on glomerular dynamics and morphology. Although
presumed to be a form of volume-dependent hypertension, it is
not possible to produce a model of nephritic hypertension
without nephritis. In our previous study, which employed clip
hypertension superimposed on NSN, the effect of hypertension
alone could be examined, and the findings showed that hyper-
tension had a more destructive effect on the glomerulus and
intrarenal vasculature in the nephritic animal. The implications
of these experimental observations relative to the progressive
course of glomerulonephritis in humans during the hypertensive
phase are far-reaching.
Little information is available regarding specific glomerular
hemodynamic responses to individual antihypertensive agents
in the normal or diseased kidney, Although such drugs may
differ in their primary action on vascular tone, by lowering
systemic blood pressure they may induce autoregulatory re-
sponses in renal resistance that could prove to be the ultimate
determinant of their influence on PGC and glomerular dynamics.
The effect of most antihypertensive agents on renal hemody-
namics may reflect mainly the kidney's response to a reduction
in systemic pressure. In chronic parenchymal renal disease, it is
likely that renal vasodilatation is close to maximal as a result of
disease-related hemodynamic adaptations to nephron loss [14].
Consequently, gbomerular capillary pressure and filtration rate
probably decline with antihypertensive therapy due to limita-
tions on further renal vasodilation. In experimental models
where renal vasodilatation is not maximal, normalization of
systemic blood pressure with a regimen similar to the one we
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used has been reported not to lower GC or prevent glomerular
injury [15, 16]. This may be attributable to hydralazine-induced
further vasodilatation.
The failure of nephritic rats in our study to maintain renal
blood flow and glomerular filtration rate with antihypertensive
therapy may be related to their having been uninephrectomized.
Reduction of renal mass in this way may lead to maximal
adaptation (vasodilatation of the intrarenal vasculature) and
thus impair autoregulation. This limitation is manifest already in
their hypertensive state, as evidenced by the increased glomer-
ular plasma flow rate and the increased glomerular capillary
pressure and filtration rate. With reduction in their blood
pressure, they demonstrate further this defect by an inability to
maintain renal perfusion. In contrast to the findings of Sakai et
al, who reported maintenance of autoregulation in two kidney
rats with bilateral NSN [17], our uninephrectomized model may
mimic more closely chronic glomerular disease in humans
where nephron loss could be responsible for maximum
vasodilatation and impaired autoregulation.
In view of the universal presence of ascites in hypertensive
animals at 2 weeks and its absence in the treated normotensive
nephritic rats, it may be that lower salt intake and diuretic-
induced extracellular volume contraction contributed to reduc-
tion in blood pressure and the pattern of renal hemodynamic
response that we observed in the treated rats [18].
Several investigators have demonstrated an ameliorative
effect of dietary protein restriction on glomerular injury in
experimental glomerulonephritis [19—23]. The reduction in di-
etary protein intake required to achieve this response has been
approximately 75%. It is highly unlikely that the 15% lesser
intake of protein by the treated rats played any significant role
in the present study, Reductions in renal hemodynamics with
restriction in dietary protein have required similar reductions in
protein intake [24]. Finally, we cannot exclude the possibility
that reduced renal blood flow in treated animals may have
resulted in decreased delivery of immune reactants to
glomeruli, thereby ameliorating glomerular damage.
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